27 studies found for:    " February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Computer Assisted Rx Education for HIV-Positives: CARE+
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: CARE+
2 Completed
Has Results
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
3 Completed
Has Results
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
4 Unknown  Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Intervention: Behavioral: Prevention Care Advocate
5 Active, not recruiting A Phase 2 Study of the Safety of Ritonavir-Boosted Elvitegravir Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Elvitegravir;   Drug: Ritonavir;   Drug: ARV regimen
6 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
7 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
8 Completed Positive Choice: Prevention for Positive Health
Conditions: HIV Infections;   Sexual Risk Behavior;   Substance Use Risks
Intervention: Behavioral: Positive Choice
9 Completed HIV Prevention Among Substance Abusing SMI
Conditions: Mentally Ill Persons;   Substance Abuse;   HIV Infections
Intervention: Behavioral: PATH
10 Completed Enhancing Oral Health Care Use by HIV Positive Individuals
Conditions: Oral Health Care;   HIV Infections;   Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention
11 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
12 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
13 Completed
Has Results
Pioglitazone to Treat Fatty Liver in People With HIV Infection
Conditions: HIV Infections;   Hepatic Steatosis;   Insulin Resistance
Intervention: Drug: Pioglitazone
14 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
15 Completed Trial of Zinc and HIV Progression in Children
Condition: HIV Infections
Intervention: Dietary Supplement: Zinc
16 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
17 Completed Safety Study of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: Placebo gel;   Drug: UC 781
18 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo
19 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: Comparator: raltegravir;   Drug: Comparator: placebo;   Drug: Comparator: lopinavir (+) ritonavir
20 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
Indicates status has not been verified in more than two years